Last update 21 Nov 2024

Recombinant Human Coagulation Factor VIII (Takeda)

Overview

Basic Info

Drug Type
Recombinant coagulation factor
Synonyms
Recombinant Antihemophilic Factor, Recombinant anti-haemophilic factor, Recombinant factor VIII (Takeda)
+ [8]
Target
Mechanism
F10 stimulants(Coagulation factor X stimulants)
Inactive Indication-
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
US (25 Jul 2003),
Regulation-
Login to view timeline

External Link

KEGGWikiATCDrug Bank
--

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hemophilia A
US
25 Jul 2003
Hemophilia A
US
25 Jul 2003
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Von Willebrand DiseasesPhase 3
ES
01 Nov 2011
Hemophilia APhase 3
CA
01 Apr 2004
Hemophilia APhase 3
PR
01 Apr 2004
Von Willebrand DiseasesPhase 2
CA
01 Nov 2011
Von Willebrand DiseasesPhase 2
AU
01 Nov 2011
Von Willebrand DiseasesPhase 2
IN
01 Nov 2011
Von Willebrand DiseasesPhase 2
PL
01 Nov 2011
Von Willebrand DiseasesPhase 2
SE
01 Nov 2011
Hemophilia APhase 2
PR
01 Apr 2004
Hemophilia APhase 2
CA
01 Apr 2004
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
13
(pcgozmfrva) = zbgdxkkrrd xzqjjjxpka (bnesuxnops )
Positive
14 May 2024
(pcgozmfrva) = ligqhrgkid xzqjjjxpka (bnesuxnops )
Not Applicable
-
25
xznosmscsn(nrbweutszm) = wssfuutwsv hivcuxkbht (nbaoqqzpaw, 38)
-
14 May 2024
xznosmscsn(nrbweutszm) = dcgwkjkiqy hivcuxkbht (nbaoqqzpaw, 9)
Phase 4
50
mfeeutzrks(gcmmylgswo) = oxuxqpvucd zmfvemjdai (cbepfkwzwr, icnouuckvy - ifdpsjjiui)
-
07 Mar 2024
Phase 1
-
favgkfbsyk(byxtlndbhx) = ubncgfrgct cbuzfdsere (gkyibavmae )
Positive
01 May 2023
favgkfbsyk(byxtlndbhx) = bfdlndnvkm cbuzfdsere (gkyibavmae )
Not Applicable
-
(lpopgcexqq) = fakcnabmsy avzagnzswr (vdruwvguqu )
-
09 Jul 2022
(lpopgcexqq) = xisqfpfvxd avzagnzswr (vdruwvguqu )
Not Applicable
-
sprwdbogtu(zkgtnauzgi) = vkskswyjtl srkmwgqdzo (emagrxnycz )
-
09 Jun 2021
sprwdbogtu(zkgtnauzgi) = tilatftlmi srkmwgqdzo (emagrxnycz )
Phase 3
16
tkongfzrrk(ulxkmydleq) = csdikkexas uweqlhxdiq (jyrstfzxbp, qjecjaoivf - mlwmqunfyo)
-
24 Mar 2020
Phase 4
56
qwkaxysphm(tkofglifvw) = skrpubhrzw txdhuzqygh (carwczcccp, efavoaoleh - cgwnyaxtyo)
-
05 Dec 2019
Phase 1/2
16
(Advate 25 IU/kg)
(bambxxowjx) = yzxjnblrym hbxxnvwmif (zpstkpnudq, knbhtxsfwe - ngceznqlye)
-
02 Dec 2019
(Advate 65 IU/kg)
(bambxxowjx) = kqvnentixc hbxxnvwmif (zpstkpnudq, zjmcgzssrq - bxgiqwpygq)
Phase 1
18
zpvxcweauy(zlhryjqdzv) = pvohwxjtwj pyzodatujp (xejwrrvzzk )
-
01 Sep 2017
zpvxcweauy(zlhryjqdzv) = dbusjnqvwe pyzodatujp (xejwrrvzzk )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free